Latest News and Press Releases

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in RR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in NAVN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Dubai, UAE, March 19, 2026 (GLOBE NEWSWIRE) -- Pepeto's presale stage sold out during a full market crash, pushing capital past $8.197 million while every other project bled. The crypto news...

Investors who lost money in PYPL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on...

Investors who lost money in TCOM after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Phase 2 pivot évaluant lasmé-cel dans la LAL-B en rechute ou réfractaire (étude BALLI-01) en cours Phase 1 : 83 % d’ORR à la dose RP2D et 100 % d’ORR dans la population cible de phase 2.Population...

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became...